Conversely, under hypoglycemic conditions, aberrant microglial activation interacts with orexigenic neuropeptide Y (NPY) neurons to suppress HPA axis activity, and microglial inhibition enhances counterregulatory responses to both insulin-induced and neurogenic hypoglycemia [131]. The gene discussed is NPY; the disease is Hypoglycemia.